Mechanism Differences: GLP-1 vs Dual Hormone Approach
Understanding the Core Difference Between Wegovy and Mounjaro Mechanisms
The fundamental difference between Wegovy and Mounjaro lies in their active ingredients and how they work in your body. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 to reduce appetite and promote feelings of fullness. Mounjaro, containing tirzepatide, takes a dual approach by targeting both GIP and GLP-1 receptors simultaneously. This dual mechanism may offer different benefits for different patients, though both require prescription-only medicine status and clinical assessment before dispensing.
Your prescriber will consider factors including your medical history, current medications, and treatment goals when determining which option suits you best. Both medications work alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management programme. At EverydayMeds (GPhC #9012878), our clinical team reviews each assessment to ensure the most appropriate treatment selection for your individual circumstances.
Wegovy vs Mounjaro Pricing: Complete Cost Breakdown with Discount Codes
Understanding the pricing difference between Wegovy and Mounjaro helps inform your treatment decision. For Wegovy, our transparent pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to access these rates, while returning customers use DOSE25. Our convenient bundle options include the Intro Duo (0.25mg & 0.5mg) at £169.99 and Ultimate Stability Trio (three 2.4mg pens) at £649.99 for uninterrupted maintenance supply.
Both treatments require dose escalation protocols, meaning you'll need multiple pen strengths during your initial months. Our Getting Started bundles provide exactly the right combination of doses for smooth progression, eliminating the need for multiple separate orders. The difference between Wegovy and Mounjaro pricing structures reflects their different dose escalation schedules and maintenance requirements, with both available through our streamlined online assessment process.
Clinical Evidence: Comparing Wegovy and Mounjaro Trial Results
The difference between Wegovy and Mounjaro extends to their clinical trial programmes, though direct comparisons should be interpreted carefully due to different study designs. Wegovy's STEP programme demonstrated that patients taking semaglutide alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events with Wegovy treatment.
Mounjaro's SURMOUNT trials evaluated tirzepatide's effectiveness using different methodologies and patient populations. Both medications have undergone rigorous MHRA evaluation and carry the Black Triangle (▼) symbol indicating additional monitoring. Your prescriber can discuss which clinical evidence profile aligns better with your health goals and medical history during your consultation.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines. When you inject Wegovy once weekly using the FlexTouch pen, it binds to GLP-1 receptors in your brain's appetite control centres, reducing hunger signals and increasing feelings of satiety after smaller meals. This mechanism may also slow gastric emptying, helping you feel fuller for longer periods. The medication works by enhancing your body's natural appetite regulation rather than artificially suppressing hunger. Understanding this mechanism helps explain why Wegovy must be combined with lifestyle modifications including a reduced-calorie diet and increased physical activity for optimal results.
Ordering Process: From Assessment to Delivery for Both Treatments
The difference between Wegovy and Mounjaro ordering processes at EverydayMeds is minimal, with both requiring the same clinical pathway. You'll complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review your assessment within 3 working days (or 24 hours with express service), determining which treatment is most suitable for your circumstances. Once approved, your medication ships via next-day delivery in temperature-controlled packaging to maintain the cold-chain integrity essential for both treatments. Remember to apply discount code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing for either medication.
Storage Requirements: Practical Differences Between Wegovy and Mounjaro
A practical difference between Wegovy and Mounjaro lies in their room temperature storage capabilities once removed from refrigeration. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks, while Mounjaro pens should be used within 21 days of leaving the fridge. Both medications must be stored at 2-8°C before first use and protected from light and freezing. This storage advantage makes Wegovy potentially more suitable for frequent travelers or those with variable schedules. Both use pre-filled pen injectors for once-weekly administration, though their dose escalation schedules differ slightly. Your prescriber will provide detailed storage and administration guidance specific to your prescribed treatment.
Dose Escalation: Wegovy vs Mounjaro Progression Schedules
The difference between Wegovy and Mounjaro includes their dose escalation timelines, though both follow gradual increase protocols to minimise side effects. Wegovy follows a 16-week escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. This structured approach allows your body to adjust gradually to increasing semaglutide levels. Planning your bundle purchases around these schedules ensures uninterrupted treatment progression without the inconvenience of frequent reordering.
Mounjaro follows its own escalation schedule designed for tirzepatide's dual mechanism action. Both treatments require commitment to the full escalation process, as jumping directly to higher doses significantly increases the risk of gastrointestinal side effects. Our bundle options are specifically designed around these escalation requirements, providing the exact combination of doses needed for smooth progression through either treatment protocol.
Making Your Treatment Choice: Wegovy vs Mounjaro Decision Factors
The decision between Wegovy and Mounjaro ultimately rests with your prescriber's clinical judgement and your individual circumstances. Factors influencing this choice include your medical history, current medications, previous weight management attempts, and specific health goals. Both are prescription-only medicines requiring ongoing monitoring and regular review appointments. Cost considerations, storage convenience, and injection frequency preferences may also influence your decision, though clinical suitability always takes precedence. Your EverydayMeds prescriber will discuss these factors during your assessment, ensuring you receive the most appropriate treatment for your situation. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you based on comprehensive evaluation of your individual needs and medical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
